Secondary histiocytic sarcoma with BRAFV600E mutation after T-cell acute lymphoblastic leukemia in a very young child with dramatic response to dabrafenib and trametinib.
Vinayak VenkataramanLucas R MassothRyan J SullivanAlison M FriedmannPublished in: Pediatric blood & cancer (2020)